205
Participants
Start Date
October 31, 2022
Primary Completion Date
May 22, 2025
Study Completion Date
July 17, 2025
Part A: Placebo (matching zibotentan capsule & matching dapagliflozin tablet)
"placebo capsule (matching zibotentan capsule)~placebo tablet (matching dapagliflozin tablet)"
Part A: zibotentan (dose B) + dapagliflozin
"zibotentan capsule~dapagliflozin tablet"
Part B: Placebo (matching zibotentan capsule & matching dapagliflozin tablet)
"placebo capsule (matching zibotentan capsule)~placebo tablet (matching dapagliflozin tablet)"
Part B: placebo (matching zibotentan capsule) + dapagliflozin
"placebo capsule (matching zibotentan capsule)~dapagliflozin tablet"
Part B: zibotentan (dose A) + dapagliflozin
"zibotentan capsule~dapagliflozin tablet"
Part B: zibotentan (dose B) + dapagliflozin
"zibotentan capsule~dapagliflozin tablet"
Part B: zibotentan (dose C) + dapagliflozin
"zibotentan capsule~dapagliflozin tablet"
Research Site, Taipei
Research Site, Vienna
Research Site, Edegem
Research Site, Hvidovre
Research Site, Bern
Research Site, Heidelberg
Research Site, Køge
Research Site, Lucerne
Research Site, Esbjerg
Research Site, Lugano
Research Site, Aarhus N
Research Site, Taipei
Research Site, The Bronx
Research Site, Charlottesville
Research Site, Richmond
Research Site, Madrid
Research Site, Madrid
Research Site, Majadahonda
Research Site, Charleston
Research Site, Toulouse
Research Site, Birmingham
Research Site, Santander
Research Site, Münster
Research Site, Angers
Research Site, Milwaukee
Research Site, Mainz
Research Site, Rochester
Research Site, Wiesbaden
Research Site, Dallas
Research Site, Paris
Research Site, Landshut
Research Site, West Hollywood
Research Site, Pasadena
Research Site, Clichy
Research Site, San Francisco
Research Site, Beijing
Research Site, Hangzhou
Research Site, Cluj-Napoca
Research Site, Guangzhou
Research Site, Chengdu
Research Site, Prague
Research Site, Prague
Research Site, Dresden
Research Site, Amsterdam
Research Site, Barcelona
Research Site, Barcelona
Research Site, Barcelona
Research Site, Birmingham
Research Site, Cambridge
Research Site, London
Lead Sponsor
AstraZeneca
INDUSTRY